AZ.TIMICOSIN ORAL

  • Sku: :   20181211-109

AZ.TIMICOSIN ORAL is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin.

Detail information

  • Composition Each ml contains:
- Tilmicosin                               250 mg
- Excipient q.s.                               1ml

        Description

AZ.TIMICOSIN ORAL is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma s.p., Pasteurella s.p. and Haemophilus s.p.p. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine. 

        Indications

AZ.TIMICOSIN is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp., Pasteurella multocida, Heamophilus sp., Actinomyces pyogenes and Mannheimia haemo- lytica in chickens, turkeys, duck, goose. 

        Administration and Dosage

Dissolve into drinking water or mix with feed for 3-5 days.

Poultry: 15-20 mg/kg bodyweight, or 1ml/12-16kg b.w., equivalent 1ml per 2-3 litres of drinking water for 3 days for the treatment and prevention of respiratory disease in chicken flocks, associated with Mycoplasma gallisepticum and M. synoviae has been demonstrated. 

       Withdrawal period

For meat:
- Broilers: 12 days.

- Turkeys: 19 days.

- Swine: 14 days.

       Presentation

Bottle of 100ml and 1000 ml.

       Veterinary use only